Global Insomnia Therapy Market Research Report 2025(Status and Outlook)

March 2025 | 234 pages | ID: G116A013B3ABEN
Bosson Research

Abstracts

Report Overview

Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.

This report provides a deep insight into the global Insomnia Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Insomnia Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Insomnia Therapy market in any manner.

Global Insomnia Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck & Co.

Sanofi

Pfizer

Takeda Pharmaceutical Company Ltd.

Purdue Pharmaceuticals L.P.

Eisai

Co. Ltd.

Meda Consumer Healthcare

Pernix Therapeutics

Vanda Pharmaceuticals

ECR Pharmaceuticals

Fidia Farmaceutici

Dainippon Sumitomo

Biocodex

Eli Lilly and Company

Ebb Therapeutics

Market Segmentation (by Type)

Non-pharmacological Therapy

Pharmacological Therapy

Market Segmentation (by Application)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Insomnia Therapy Market
• Overview of the regional outlook of the Insomnia Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Insomnia Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Insomnia Therapy
1.2 Key Market Segments
1.2.1 Insomnia Therapy Segment by Type
1.2.2 Insomnia Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Insomnia Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Insomnia Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Insomnia Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Insomnia Therapy Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Insomnia Therapy Product Life Cycle
3.3 Global Insomnia Therapy Sales by Manufacturers (2020-2025)
3.4 Global Insomnia Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Insomnia Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Insomnia Therapy Manufacturing Sites, Area Served, Product Type
3.8 Insomnia Therapy Market Competitive Situation and Trends
3.8.1 Insomnia Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Insomnia Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Insomnia Therapy Industry Chain Analysis
4.1 Insomnia Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Insomnia Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Insomnia Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Insomnia Therapy Market
5.7 ESG Ratings of Leading Companies
6 Global Insomnia Therapy Market by Region
6.1 Global Insomnia Therapy Market Size by Region
6.1.1 Global Insomnia Therapy Market Size by Region
6.1.2 Global Insomnia Therapy Market Size Market Share by Region
6.2 Global Insomnia Therapy Sales by Region
6.2.1 Global Insomnia Therapy Sales by Region
6.2.2 Global Insomnia Therapy Sales Market Share by Region
7 North America Market Overview
7.1 North America Insomnia Therapy Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Insomnia Therapy Market Size by Type
7.3 North America Insomnia Therapy Market Size by Application
8 Europe Market Overview
8.1 Europe Insomnia Therapy Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Insomnia Therapy Market Size by Type
8.3 Europe Insomnia Therapy Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Insomnia Therapy Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Insomnia Therapy Market Size by Type
9.3 Asia-Pacific Insomnia Therapy Market Size by Application
10 South America Market Overview
10.1 South America Insomnia Therapy Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Insomnia Therapy Market Size by Type
10.3 South America Insomnia Therapy Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Insomnia Therapy Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Insomnia Therapy Market Size by Type
11.3 Middle East and Africa Insomnia Therapy Market Size by Application
12 Insomnia Therapy Market Production by Region
12.1 Global Production of Insomnia Therapy by Region(2020-2025)
12.2 Global Insomnia Therapy Revenue Market Share by Region (2020-2025)
12.3 Global Insomnia Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Insomnia Therapy Production
12.4.1 North America Insomnia Therapy Production Growth Rate (2020-2025)
12.4.2 North America Insomnia Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Insomnia Therapy Production
12.5.1 Europe Insomnia Therapy Production Growth Rate (2020-2025)
12.5.2 Europe Insomnia Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Insomnia Therapy Production (2020-2025)
12.6.1 Japan Insomnia Therapy Production Growth Rate (2020-2025)
12.6.2 Japan Insomnia Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Insomnia Therapy Production (2020-2025)
12.7.1 China Insomnia Therapy Production Growth Rate (2020-2025)
12.7.2 China Insomnia Therapy Production, Revenue, Price and Gross Margin (2020-2025)
13 Insomnia Therapy Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Insomnia Therapy Sales Market Share by Type (2020-2033)
13.3 Global Insomnia Therapy Market Size Market Share by Type (2020-2033)
13.4 Global Insomnia Therapy Price by Type (2020-2033)
14 Insomnia Therapy Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Insomnia Therapy Market Sales by Application (2020-2033)
14.3 Global Insomnia Therapy Market Size (M USD) by Application (2020-2033)
14.4 Global Insomnia Therapy Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Merck and Co.
15.1.1 Merck and Co. Basic Information
15.1.2 Merck and Co. Insomnia Therapy Product Overview
15.1.3 Merck and Co. Insomnia Therapy Product Market Performance
15.1.4 Merck and Co. Business Overview
15.1.5 Merck and Co. SWOT Analysis
15.1.6 Merck and Co. Recent Developments
15.2 Sanofi
15.2.1 Sanofi Basic Information
15.2.2 Sanofi Insomnia Therapy Product Overview
15.2.3 Sanofi Insomnia Therapy Product Market Performance
15.2.4 Sanofi Business Overview
15.2.5 Sanofi SWOT Analysis
15.2.6 Sanofi Recent Developments
15.3 Pfizer
15.3.1 Pfizer Basic Information
15.3.2 Pfizer Insomnia Therapy Product Overview
15.3.3 Pfizer Insomnia Therapy Product Market Performance
15.3.4 Pfizer Business Overview
15.3.5 Pfizer SWOT Analysis
15.3.6 Pfizer Recent Developments
15.4 Takeda Pharmaceutical Company Ltd.
15.4.1 Takeda Pharmaceutical Company Ltd. Basic Information
15.4.2 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Overview
15.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Market Performance
15.4.4 Takeda Pharmaceutical Company Ltd. Business Overview
15.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments
15.5 Purdue Pharmaceuticals L.P.
15.5.1 Purdue Pharmaceuticals L.P. Basic Information
15.5.2 Purdue Pharmaceuticals L.P. Insomnia Therapy Product Overview
15.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Product Market Performance
15.5.4 Purdue Pharmaceuticals L.P. Business Overview
15.5.5 Purdue Pharmaceuticals L.P. Recent Developments
15.6 Eisai
15.6.1 Eisai Basic Information
15.6.2 Eisai Insomnia Therapy Product Overview
15.6.3 Eisai Insomnia Therapy Product Market Performance
15.6.4 Eisai Business Overview
15.6.5 Eisai Recent Developments
15.7 Co. Ltd.
15.7.1 Co. Ltd. Basic Information
15.7.2 Co. Ltd. Insomnia Therapy Product Overview
15.7.3 Co. Ltd. Insomnia Therapy Product Market Performance
15.7.4 Co. Ltd. Business Overview
15.7.5 Co. Ltd. Recent Developments
15.8 Meda Consumer Healthcare
15.8.1 Meda Consumer Healthcare Basic Information
15.8.2 Meda Consumer Healthcare Insomnia Therapy Product Overview
15.8.3 Meda Consumer Healthcare Insomnia Therapy Product Market Performance
15.8.4 Meda Consumer Healthcare Business Overview
15.8.5 Meda Consumer Healthcare Recent Developments
15.9 Pernix Therapeutics
15.9.1 Pernix Therapeutics Basic Information
15.9.2 Pernix Therapeutics Insomnia Therapy Product Overview
15.9.3 Pernix Therapeutics Insomnia Therapy Product Market Performance
15.9.4 Pernix Therapeutics Business Overview
15.9.5 Pernix Therapeutics Recent Developments
15.10 Vanda Pharmaceuticals
15.10.1 Vanda Pharmaceuticals Basic Information
15.10.2 Vanda Pharmaceuticals Insomnia Therapy Product Overview
15.10.3 Vanda Pharmaceuticals Insomnia Therapy Product Market Performance
15.10.4 Vanda Pharmaceuticals Business Overview
15.10.5 Vanda Pharmaceuticals Recent Developments
15.11 ECR Pharmaceuticals
15.11.1 ECR Pharmaceuticals Basic Information
15.11.2 ECR Pharmaceuticals Insomnia Therapy Product Overview
15.11.3 ECR Pharmaceuticals Insomnia Therapy Product Market Performance
15.11.4 ECR Pharmaceuticals Business Overview
15.11.5 ECR Pharmaceuticals Recent Developments
15.12 Fidia Farmaceutici
15.12.1 Fidia Farmaceutici Basic Information
15.12.2 Fidia Farmaceutici Insomnia Therapy Product Overview
15.12.3 Fidia Farmaceutici Insomnia Therapy Product Market Performance
15.12.4 Fidia Farmaceutici Business Overview
15.12.5 Fidia Farmaceutici Recent Developments
15.13 Dainippon Sumitomo
15.13.1 Dainippon Sumitomo Basic Information
15.13.2 Dainippon Sumitomo Insomnia Therapy Product Overview
15.13.3 Dainippon Sumitomo Insomnia Therapy Product Market Performance
15.13.4 Dainippon Sumitomo Business Overview
15.13.5 Dainippon Sumitomo Recent Developments
15.14 Biocodex
15.14.1 Biocodex Basic Information
15.14.2 Biocodex Insomnia Therapy Product Overview
15.14.3 Biocodex Insomnia Therapy Product Market Performance
15.14.4 Biocodex Business Overview
15.14.5 Biocodex Recent Developments
15.15 Eli Lilly and Company
15.15.1 Eli Lilly and Company Basic Information
15.15.2 Eli Lilly and Company Insomnia Therapy Product Overview
15.15.3 Eli Lilly and Company Insomnia Therapy Product Market Performance
15.15.4 Eli Lilly and Company Business Overview
15.15.5 Eli Lilly and Company Recent Developments
15.16 Ebb Therapeutics
15.16.1 Ebb Therapeutics Basic Information
15.16.2 Ebb Therapeutics Insomnia Therapy Product Overview
15.16.3 Ebb Therapeutics Insomnia Therapy Product Market Performance
15.16.4 Ebb Therapeutics Business Overview
15.16.5 Ebb Therapeutics Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Insomnia Therapy Market Size by Type (M USD)
Table 4. Global Insomnia Therapy Market Size by Application (M USD)
Table 5. Insomnia Therapy Market Size Comparison by Region (M USD)
Table 6. Global Insomnia Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Insomnia Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Insomnia Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Insomnia Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Therapy as of 2024)
Table 11. Global Market Insomnia Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Insomnia Therapy Manufacturing Sites and Area Served
Table 13. Manufacturers Insomnia Therapy Product Type
Table 14. Global Insomnia Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Insomnia Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Insomnia Therapy Market Size Comparison by Region (M USD)
Table 26. Global Insomnia Therapy Market Size by Region (2020-2033) & (M USD)
Table 27. Global Insomnia Therapy Market Size Market Share by Region (2020-2033)
Table 28. Global Insomnia Therapy Sales by Region (2020-2033) & (K Units)
Table 29. Global Insomnia Therapy Sales Market Share by Region (2020-2033)
Table 30. North America Insomnia Therapy Market Size by Country (2020-2033) & (M USD)
Table 31. North America Insomnia Therapy Sales by Country (2020-2033) & (K Units)
Table 32. North America Insomnia Therapy Sales by Type (K Units)
Table 33. North America Insomnia Therapy Market Size by Type (M USD)
Table 34. North America Insomnia Therapy Sales (K Units) by Type (2020-2033)
Table 35. North America Insomnia Therapy Market Size (M USD) by Type (2020-2033)
Table 36. North America Insomnia Therapy Sales by Application (K Units)
Table 37. North America Insomnia Therapy Market Size by Application (M USD)
Table 38. North America Insomnia Therapy Sales (K Units) by Application (2020-2033)
Table 39. North America Insomnia Therapy Market Size (M USD) by Application (2020-2033)
Table 40. Europe Insomnia Therapy Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Insomnia Therapy Sales by Country (2020-2033) & (K Units)
Table 42. Europe Insomnia Therapy Sales by Type (K Units)
Table 43. Europe Insomnia Therapy Market Size by Type (M USD)
Table 44. Europe Insomnia Therapy Sales (K Units) by Type (2020-2033)
Table 45. Europe Insomnia Therapy Market Size (M USD) by Type (2020-2033)
Table 46. Europe Insomnia Therapy Sales by Application (K Units)
Table 47. Europe Insomnia Therapy Market Size by Application (M USD)
Table 48. Europe Insomnia Therapy Sales (K Units) by Application (2020-2033)
Table 49. Europe Insomnia Therapy Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Insomnia Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Insomnia Therapy Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Insomnia Therapy Sales by Type (K Units)
Table 53. Asia-Pacific Insomnia Therapy Market Size by Type (M USD)
Table 54. Asia-Pacific Insomnia Therapy Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Insomnia Therapy Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Insomnia Therapy Sales by Application (K Units)
Table 57. Asia-Pacific Insomnia Therapy Market Size by Application (M USD)
Table 58. Asia-Pacific Insomnia Therapy Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Insomnia Therapy Market Size (M USD) by Application (2020-2025)
Table 60. South America Insomnia Therapy Market Size by Country (2020-2033) & (M USD)
Table 61. South America Insomnia Therapy Sales by Country (2020-2033) & (K Units)
Table 62. South America Insomnia Therapy Sales by Type (K Units)
Table 63. South America Insomnia Therapy Market Size by Type (M USD)
Table 64. South America Insomnia Therapy Sales (K Units) by Type (2020-2033)
Table 65. South America Insomnia Therapy Market Size (M USD) by Type (2020-2033)
Table 66. South America Insomnia Therapy Sales by Application (K Units)
Table 67. South America Insomnia Therapy Market Size by Application (M USD)
Table 68. South America Insomnia Therapy Sales (K Units) by Application (2020-2033)
Table 69. South America Insomnia Therapy Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Insomnia Therapy Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Insomnia Therapy Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Insomnia Therapy Sales by Type (K Units)
Table 73. Middle East and Africa Insomnia Therapy Market Size by Type (M USD)
Table 74. Middle East and Africa Insomnia Therapy Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Insomnia Therapy Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Insomnia Therapy Sales by Application (K Units)
Table 77. Middle East and Africa Insomnia Therapy Market Size by Application (M USD)
Table 78. Middle East and Africa Insomnia Therapy Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Insomnia Therapy Market Size (M USD) by Application (2020-2033)
Table 80. Global Insomnia Therapy Production (K Units) by Region(2020-2025)
Table 81. Global Insomnia Therapy Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Insomnia Therapy Revenue Market Share by Region (2020-2025)
Table 83. Global Insomnia Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Insomnia Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Insomnia Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Insomnia Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Insomnia Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Insomnia Therapy Sales by Type (K Units)
Table 89. Global Insomnia Therapy Market Size by Type (M USD)
Table 90. Global Insomnia Therapy Sales (K Units) by Type (2020-2033)
Table 91. Global Insomnia Therapy Sales Market Share by Type (2020-2033)
Table 92. Global Insomnia Therapy Market Size (M USD) by Type (2020-2033)
Table 93. Global Insomnia Therapy Market Size Share by Type (2020-2033)
Table 94. Global Insomnia Therapy Sales (K Units) by Application
Table 95. Global Insomnia Therapy Market Size by Application(M USD)
Table 96. Global Insomnia Therapy Sales by Application (2020-2033) & (K Units)
Table 97. Global Insomnia Therapy Sales Market Share by Application (2020-2033)
Table 98. Global Insomnia Therapy Market Size by Application (2020-2033) & (M USD)
Table 99. Global Insomnia Therapy Market Share by Application (2020-2033)
Table 100. Global Insomnia Therapy Sales Growth Rate by Application (2020-2033)
Table 101. Merck and Co. Basic Information
Table 102. Merck and Co. Insomnia Therapy Product Overview
Table 103. Merck and Co. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Merck and Co. Business Overview
Table 105. Merck and Co. SWOT Analysis
Table 106. Merck and Co. Recent Developments
Table 107. Sanofi Basic Information
Table 108. Sanofi Insomnia Therapy Product Overview
Table 109. Sanofi Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Sanofi Business Overview
Table 111. Sanofi SWOT Analysis
Table 112. Sanofi Recent Developments
Table 113. Pfizer Basic Information
Table 114. Pfizer Insomnia Therapy Product Overview
Table 115. Pfizer Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Pfizer Business Overview
Table 117. Pfizer SWOT Analysis
Table 118. Pfizer Recent Developments
Table 119. Takeda Pharmaceutical Company Ltd. Basic Information
Table 120. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product Overview
Table 121. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Takeda Pharmaceutical Company Ltd. Business Overview
Table 123. Takeda Pharmaceutical Company Ltd. Recent Developments
Table 124. Purdue Pharmaceuticals L.P. Basic Information
Table 125. Purdue Pharmaceuticals L.P. Insomnia Therapy Product Overview
Table 126. Purdue Pharmaceuticals L.P. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Purdue Pharmaceuticals L.P. Business Overview
Table 128. Purdue Pharmaceuticals L.P. Recent Developments
Table 129. Eisai Basic Information
Table 130. Eisai Insomnia Therapy Product Overview
Table 131. Eisai Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Eisai Business Overview
Table 133. Eisai Recent Developments
Table 134. Co. Ltd. Basic Information
Table 135. Co. Ltd. Insomnia Therapy Product Overview
Table 136. Co. Ltd. Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Co. Ltd. Business Overview
Table 138. Co. Ltd. Recent Developments
Table 139. Meda Consumer Healthcare Basic Information
Table 140. Meda Consumer Healthcare Insomnia Therapy Product Overview
Table 141. Meda Consumer Healthcare Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Meda Consumer Healthcare Business Overview
Table 143. Meda Consumer Healthcare Recent Developments
Table 144. Pernix Therapeutics Basic Information
Table 145. Pernix Therapeutics Insomnia Therapy Product Overview
Table 146. Pernix Therapeutics Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Pernix Therapeutics Business Overview
Table 148. Pernix Therapeutics Recent Developments
Table 149. Vanda Pharmaceuticals Basic Information
Table 150. Vanda Pharmaceuticals Insomnia Therapy Product Overview
Table 151. Vanda Pharmaceuticals Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Vanda Pharmaceuticals Business Overview
Table 153. Vanda Pharmaceuticals Recent Developments
Table 154. ECR Pharmaceuticals Basic Information
Table 155. ECR Pharmaceuticals Insomnia Therapy Product Overview
Table 156. ECR Pharmaceuticals Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. ECR Pharmaceuticals Business Overview
Table 158. ECR Pharmaceuticals Recent Developments
Table 159. Fidia Farmaceutici Basic Information
Table 160. Fidia Farmaceutici Insomnia Therapy Product Overview
Table 161. Fidia Farmaceutici Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Fidia Farmaceutici Business Overview
Table 163. Fidia Farmaceutici Recent Developments
Table 164. Dainippon Sumitomo Basic Information
Table 165. Dainippon Sumitomo Insomnia Therapy Product Overview
Table 166. Dainippon Sumitomo Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Dainippon Sumitomo Business Overview
Table 168. Dainippon Sumitomo Recent Developments
Table 169. Biocodex Basic Information
Table 170. Biocodex Insomnia Therapy Product Overview
Table 171. Biocodex Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Biocodex Business Overview
Table 173. Biocodex Recent Developments
Table 174. Eli Lilly and Company Basic Information
Table 175. Eli Lilly and Company Insomnia Therapy Product Overview
Table 176. Eli Lilly and Company Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Eli Lilly and Company Business Overview
Table 178. Eli Lilly and Company Recent Developments
Table 179. Ebb Therapeutics Basic Information
Table 180. Ebb Therapeutics Insomnia Therapy Product Overview
Table 181. Ebb Therapeutics Insomnia Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 182. Ebb Therapeutics Business Overview
Table 183. Ebb Therapeutics Recent Developments
List of Figures
Figure 1. Product Picture of Insomnia Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Insomnia Therapy Market Size (M USD), 2024-2033
Figure 5. Global Insomnia Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Insomnia Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Insomnia Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Insomnia Therapy Product Life Cycle
Figure 13. Insomnia Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Insomnia Therapy Revenue Share by Manufacturers in 2024
Figure 15. Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Insomnia Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Insomnia Therapy Revenue in 2024
Figure 18. Industry Chain Map of Insomnia Therapy
Figure 19. Global Insomnia Therapy Market PEST Analysis
Figure 20. Global Insomnia Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Insomnia Therapy Market Size by Region
Figure 27. Global Insomnia Therapy Market Size Market Share by Region (2020-2033)
Figure 28. Global Insomnia Therapy Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Insomnia Therapy Market Size (M USD) by Country
Figure 33. USA Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Insomnia Therapy Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Insomnia Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Insomnia Therapy Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Insomnia Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Insomnia Therapy Market Size (M USD)by Type
Figure 40. North America Insomnia Therapy Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Insomnia Therapy Market Size (M USD) by Country
Figure 45. Germany Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Insomnia Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Insomnia Therapy Market Size (M USD) by Type
Figure 56. Europe Insomnia Therapy Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Insomnia Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Insomnia Therapy Market Size (M USD) by Country
Figure 61. China Insomnia Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Insomnia Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Insomnia Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Insomnia Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Insomnia Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Insomnia Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Insomnia Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Insomnia Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Insomnia Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Insomnia Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Insomnia Therapy Market Size (M USD) by Type
Figure 72. Asia-Pacific Insomnia Therapy Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Insomnia Therapy Market Size (M USD) by Country
Figure 77. Brazil Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Insomnia Therapy Market Size (M USD) by Type
Figure 84. South America Insomnia Therapy Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Insomnia Therapy Market Size (M USD) by Country
Figure 89. Saudi Arabia Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Insomnia Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Insomnia Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Insomnia Therapy Market Size (M USD) by Type
Figure 100. Middle East and Africa Insomnia Therapy Market Size (M USD) by Application
Figure 101. Global Insomnia Therapy Production Market Share by Region (2020-2025)
Figure 102. North America Insomnia Therapy Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Insomnia Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Insomnia Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. China Insomnia Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Insomnia Therapy Market Size by Type (M USD)
Figure 108. Sales Market Share of Insomnia Therapy by Type (2020-2033)
Figure 109. Sales Market Share of Insomnia Therapy by Type in 2024
Figure 110. Market Size Share of Insomnia Therapy by Type (2020-2033)
Figure 111. Market Size Share of Insomnia Therapy by Type in 2024
Figure 112. Global Insomnia Therapy Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Insomnia Therapy Market Size by Application(M USD)
Figure 115. Global Insomnia Therapy Market Share by Application
Figure 116. Global Insomnia Therapy Sales Market Share by Application (2020-2033)
Figure 117. Global Insomnia Therapy Sales Market Share by Application in 2024
Figure 118. Global Insomnia Therapy Market Share by Application (2020-2033)
Figure 119. Global Insomnia Therapy Market Share by Application in 2024
Figure 120. Global Insomnia Therapy Sales Growth Rate by Application (2020-2033)